Professor Matthew Simunovic
People_

Professor Matthew Simunovic

MB BChir PhD FRANZCO
Professor of Ophthalmology and Visual Science
Faculty of Medicine and Health
Clinical Ophthalmology and Eye Health
Save Sight Institute
Professor Matthew Simunovic

Matthew Simunovic is Professor of Ophthalmology & Visual Science at the Save Sight Institute where he leads the Retinal Disease and Rescue Group. Additionally, he is a senior consultant ophthalmic surgeon at Sydney Eye Hospital and the Sydney Children's Hospitals Netork where he subspecialises in surgery and diseases of the retina. Prof. Simunovic's research interests include emerging treatments for retinal diseases, experimental vitreoretinal surgery and visual psychophysics. He was the first Australian ophthalmologist to be awarded a Career Development Award from the Foundation Fighting Blindness USA and is supported by major grant funding from the Macular Disease Foundation Australia and the NHMRC. Prof. Simunovic is a member of the Macula Society and the American Ophthalmological Society.

1. Laboratory research

Prof. Simunovic's laboratory research is currently focused on addressing novel treatments for inherited and other retinal diseases. One of the difficulties in developing treatments for IRD is that more than 300 genes have been implicated: this is compound by the fact the causative mutations cannot be identified in around 30% of patients. A key feature of our approach is the development of treatments which are causative-gene independent, thereby addressing a critical unmet need.

  • Optogenetics. The common final pathway to vision loss in IRD is the loss of photoreceptor function. The second-order and third-order neurons that normally convey information from the photoreceptors to the brain persist. The majority of optogenetic approaches seek to render these cells light-sensitive through the introduction of genetic sequences coding for Type I (microbial) or Type II (mammalian) opsins. We are investigating the rescue of vision using.novel vectors that deliver sequences for opsins designed to provide ecologically relevant light-sensitivity.
  • Retinal progenitor cells. We have recently identified the spontaneous production of retinal cells with progenitor characteristics from living human donor surgical explants. Ongoing work is characterising these cells, including the genetic and proteomic profile.
  • Retinal bioglue. Retinal detachment is the commonest reason for emergency surgery to preserve or restore sight. Despite surgical and imaging advances, the success rates and morbidity of retinal detachment repair have not drastically changed over the past several decades. We are currently investigating bioglues as a means of sealing retinal tears: these are aimed at hastening recovery and improving surgical outcomes.

2. Experimental vitreoretinal surgery

Emerging treatments for retinal disease demand novel surgical approaches. Recent work has included:

3. Functional biomarkers in retinal disease

Commonly conducted tests (e.g. visual acuity) poorly characterise visual experience: furthermore, they may fail to capture the progression of disease and improvements following therapy. Therefore, new biomarkers for retinal disease need to be developed and validated:

4. Clinical trials & Clinical Research

Together with colleagues in the vitreoretinal and medical retinal units at Sydney Eye Hospital, Prof. Simunovic is involved in clinical research. Key findings have included the first empirical evidence for an association between intravitreal injection and Streptococcus spp. endophthalmitis. Additionally, he is involved in clinical trials of new treatments for retinal diseases, including:

  • The ONL Study (ClinicalTrials.gov NCT03780972). I am the PI for this phase I trial of a novel neuroprotective factor for patients with macula-off rhegmatogenous retinal detachment
  • Renexus Phase III Trial (ClinicalTrials.gov NCT03316300). This is a phase III trial of a CNTF implant for MacTel II, which is being conducted by the Macular Research Group, with my group providing surgical expertise. We have performed the most implantations of any site worldwide to date
  • 1-step vs 2-step sub-retinal injection trial (ACTRN12619001121156). This is an investigator-initiated randomised controlled trial comparing different approaches to sub-retinal drug delivery which has quantified drug loss in humans, in vivo and has identificed the 2-step approach as the preferred technique for subretinaldelivery of therapeutics such as gene therapy

5. Registries

Registries provide a powerful means of analysing the natural history of disease processes and outcomes of treatments. Prof. Simunovic is involved in the following registries:

  • Chief Investigator of a new Save Sight Registry for Inherited Retinal Disease call Fight Inherited Retinal Blindness!, which has an international steering committee of investigators from Australia, New Zealand, North America, the United Kingdom, Belgium, Germany and Switzerland. A beta version is currently in testing in preparation for roll-out.
  • Steering committee member of the ANZSRS Surgical Registry, which is led by A/Prof. Rohan Essex at ANU.

Key Awards

Admitted to the American Ophthalmological Society

Elected to the Macula Society

Foundation Fighting Blindness Career Development Award

RANZCO Eye Foundation/Novartis Fellowship

Bayer Global Ophthalmology Awards Program Fellowship

ARVO MIT Outstanding Poster Award

ARVO International Travel Grant

RANZCO/Bayer Australia Scholarship

Sydney Eye Hospital Alumni Association Travelling Fellowship

Norman Rose Travelling Scholarship, Sydney Hospitallers

The Duke-Elder Examination Prize, Royal College of Ophthalmologists

The Patrick Trevor-Roper Award, Royal College of Ophthalmologists

Foulkes Foundation Fellowship, The Foulkes Foundation

The Packer Scholarship, Cambridge Commonwealth Trust

The Wellcome Research Prize, The Wellcome Trust

Department of Surgery Prize, University of Cambridge

E. M. Burnett Prize, University of Cambridge

The Denis Dooley Prize, University of Cambridge

Neurosciences and Mental Health

Publications

Book Chapters

  • Mack, H., Hassall, M., Hall, A., Simunovic, M., Fraser-Bell, S., Ayton, L. (2021). Cystoid Macular Edema. In Not known (Eds.), Comprehensive Pharmacology, (pp. 1-37). TBC. [More Information]
  • Simunovic, M., Mack, H., Ayton, L., Hassall, M. (2021). Gene Therapy, Diet and Drug Approaches to Treating Inherited Retinal Disease. In Not known (Eds.), Comprehensive Pharmacology, (pp. 1-31). TBC. [More Information]
  • Hassall, M., Simunovic, M. (2020). Retinal Gene Therapy. In Andrew Chang, William F. Mieler, Masahito Ohji (Eds.), Macular Surgery - Current Practice and Trends, (pp. 487-515). Singapore: Springer Nature Singapore. [More Information]

Journals

  • Robertson, E., Hetherington, K., Prain, M., Hall, J., Boyd, L., Boyd, R., Shepard, E., Feller, H., Karandrews, S., O'Hare, F., Simunovic, M., Jamieson, R., Ma, A., Gonzalez Cordero, A., et al (2025). Dismantling barriers to research and clinical care for individuals with a vision impairment. Medical Journal of Australia. [More Information]
  • Simunovic, M., Prime, Z., Chow, R., Shao, E., Madanat, Z., Osaadon, P., Yeo, T., Oo, K., Too, L. (2025). The 1-Step Versus 2-Step Subretinal Injection Trial (1,2-Sit) - A Randomized Controlled Trial to compare Drug Reflux Following Subretinal Injection. American Journal of Ophthalmology. [More Information]
  • Simunovic, M., Moore, A., Grigg, J., Sergouniotis, P., Mahroo, O., Vincent, A., Singh, M., Fischer, M., Edwards, T., Mack, H., Jamieson, R., Gillies, M., Barthelmes, D., et al (2025). The Fight Inherited Retinal Blindness! Project: A New Treatment Outcome and Natural History Registry for Inherited Retinal Disease. Retina, 45(2), 286-295. [More Information]

Conferences

  • Akter, N., Perry, S., Fletcher, J., Simunovic, M., Roy, M. (2020). Automated Artifacts and Noise Removal from Optical Coherence Tomography Images Using Deep Learning Technique. 2020 IEEE Symposium Series on Computational Intelligence (SSCI 2020), Canberra: Institute of Electrical and Electronics Engineers (IEEE). [More Information]

2025

  • Robertson, E., Hetherington, K., Prain, M., Hall, J., Boyd, L., Boyd, R., Shepard, E., Feller, H., Karandrews, S., O'Hare, F., Simunovic, M., Jamieson, R., Ma, A., Gonzalez Cordero, A., et al (2025). Dismantling barriers to research and clinical care for individuals with a vision impairment. Medical Journal of Australia. [More Information]
  • Simunovic, M., Prime, Z., Chow, R., Shao, E., Madanat, Z., Osaadon, P., Yeo, T., Oo, K., Too, L. (2025). The 1-Step Versus 2-Step Subretinal Injection Trial (1,2-Sit) - A Randomized Controlled Trial to compare Drug Reflux Following Subretinal Injection. American Journal of Ophthalmology. [More Information]
  • Simunovic, M., Moore, A., Grigg, J., Sergouniotis, P., Mahroo, O., Vincent, A., Singh, M., Fischer, M., Edwards, T., Mack, H., Jamieson, R., Gillies, M., Barthelmes, D., et al (2025). The Fight Inherited Retinal Blindness! Project: A New Treatment Outcome and Natural History Registry for Inherited Retinal Disease. Retina, 45(2), 286-295. [More Information]

2024

  • Simunovic, M., Mammo, Z. (2024). Mechanisms of cone sensitivity loss in retinitis pigmentosa. Ophthalmic and Physiological Optics. [More Information]
  • Wong, W., Tham, Y., Ayton, L., Britten-Jones, A., Edwards, T., Grigg, J., Simunovic, M., Chen, F., Jin, Z., Shen, R., et al (2024). Practice Patterns and Challenges in Managing Inherited Retinal Diseases Across Asia-Pacific: A Survey from the APIED Network. Asia-Pacific Journal of Ophthalmology, 13(5), 100098. [More Information]
  • Wong, W., Tham, Y., Simunovic, M., Chen, F., Luu, C., Chen, H., Jin, Z., Shen, R., Li, S., Sui, R., et al (2024). Rationale and protocol paper for the Asia Pacific Network for inherited eye diseases. Asia-Pacific Journal of Ophthalmology, 13(1), 100030. [More Information]

2023

  • Das, T., Joseph, J., Simunovic, M., Grzybowski, A., Chen, K., Dave, V., Sharma, S., Staropoli, P., Flynn, H. (2023). Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives. Progress in Retinal and Eye Research, 97, 101218. [More Information]
  • Sherwood, C., Crovador, R., Posar, J., Brichta, N., Simunovic, M., Louie, F., Dastoor, P., Brichta, A., Cairney, J., Holmes, N., Griffith, M., et al (2023). Design Parameters and Human Biocompatibility Assessment Protocols for Organic Semiconducting Neural Interfaces: Toward a Printed Artificial Retina with Color Vision. Advanced Materials Interfaces, 10(2202229), 1-15. [More Information]

2022

  • Akter, N., Fletcher, J., Perry, S., Simunovic, M., Briggs, N., Roy, M. (2022). Glaucoma diagnosis using multi-feature analysis and a deep learning technique. Scientific Reports, 12(1), 8064. [More Information]
  • Simunovic, M., Hess, K., Gillies, M. (2022). IMPAIRMENTS IN CONE PIGMENT REGENERATION AND ABSOLUTE THRESHOLD IN MACULAR TELANGIECTASIA TYPE 2. Retina, 42(3), 569-575. [More Information]
  • Simunovic, M., Gillies, M. (2022). IMPAIRMENTS OF L-CONE/M-CONE AND S-CONE-MEDIATED COLOR DISCRIMINATION IN MACULAR TELANGIECTASIA TYPE II. Retina, 42(3), 576-580. [More Information]

2021

  • Mack, H., Hassall, M., Hall, A., Simunovic, M., Fraser-Bell, S., Ayton, L. (2021). Cystoid Macular Edema. In Not known (Eds.), Comprehensive Pharmacology, (pp. 1-37). TBC. [More Information]
  • Shao, E., Yates, W., Ho, I., Chang, A., Simunovic, M. (2021). Endophthalmitis: Changes in Presentation, Management and the Role of Early Vitrectomy. Ophthalmology and Therapy, 10(4), 877-890. [More Information]
  • Simunovic, M., Mack, H., Ayton, L., Hassall, M. (2021). Gene Therapy, Diet and Drug Approaches to Treating Inherited Retinal Disease. In Not known (Eds.), Comprehensive Pharmacology, (pp. 1-31). TBC. [More Information]

2020

  • Simunovic, M., Shao, E., Osaadon, P. (2020). Ab-externo drainage with continuous anterior chamber infusion for non-resolving exudative retinal detachment: a case report. BMC Ophthalmology, 20(1), 349. [More Information]
  • Akter, N., Perry, S., Fletcher, J., Simunovic, M., Roy, M. (2020). Automated Artifacts and Noise Removal from Optical Coherence Tomography Images Using Deep Learning Technique. 2020 IEEE Symposium Series on Computational Intelligence (SSCI 2020), Canberra: Institute of Electrical and Electronics Engineers (IEEE). [More Information]
  • Hassall, M., Simunovic, M. (2020). Retinal Gene Therapy. In Andrew Chang, William F. Mieler, Masahito Ohji (Eds.), Macular Surgery - Current Practice and Trends, (pp. 487-515). Singapore: Springer Nature Singapore. [More Information]

2019

  • Simunovic, M., Shen, W., Lin, J., Protti, D., Lisowski, L., Gillies, M. (2019). Optogenetic approaches to vision restoration. Experimental Eye Research, 178, 15-26. [More Information]
  • Ong, A., Te, N., Zagora, S., Symes, R., Yates, W., Chang, A., McCluskey, P., Simunovic, M. (2019). Post-surgical versus post-intravitreal injection endophthalmitis: changing patterns in causative flora. Clinical and Experimental Ophthalmology, 47(1), 57-62. [More Information]
  • Xue, K., Edwards, T., Meenik, H., Beelen, M., Naus, G., Simunovic, M., De Smet, M., MacLaren, R. (2019). Robot-Assisted Retinal Surgery: Overcoming Human Limitations. In Masahito Ohji (Eds.), Surgical Retina, (pp. 109-114). Singapore: Springer. [More Information]

2018

  • Edwards, T., Cottriall, C., Xue, K., Simunovic, M., Ramsden, J., Zrenner, E., MacLaren, R. (2018). Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa. Ophthalmology, 125(3), 432-443. [More Information]
  • Seitz, I., Jolly, J., Fischer, M., Simunovic, M. (2018). Colour discrimination ellipses in choroideremia. Graefe's Archive for Clinical and Experimental Ophthalmology, 256(4), 665-673. [More Information]
  • Edwards, T., Xue, K., Meenink, H., Beelen, M., Naus, G., Simunovic, M., Latasiewicz, M., Farmery, A., De Smet, M., MacLaren, R. (2018). First-in-human study of the safety and viability of intraocular robotic surgery. Nature Biomedical Engineering, 2(9), 649-656. [More Information]

2017

  • Simunovic, M., Xue, K., Jolly, J., MacLaren, R. (2017). Structural and Functional Recovery Following Limited Iatrogenic Macular Detachment for Retinal Gene Therapy. JAMA Ophthalmology, 135(3), 234-241. [More Information]
  • Simunovic, M., Xue, K., MacLaren, R. (2017). Using Rho Kinase Inhibitors for Retinal Detachment: In Reply. JAMA Ophthalmology, 135(8), 895-896. [More Information]

2016

  • Simunovic, M. (2016). Acquired Color Vision Deficiency. Survey of Ophthalmology, 61(2), 132-155. [More Information]
  • Fahim, A., Simunovic, M., Mammo, Z., Mitry, D., Pakzad-Vaezi, K., Bradley, P., Mahroo, O. (2016). Comparison of ophthalmic training in 6 English-speaking countries. Canadian Journal of Ophthalmology, 51(3), 212-218. [More Information]
  • Simunovic, M., Moore, A., MacLaren, R. (2016). Selective Automated Perimetry Under Photopic, Mesopic, and Scotopic Conditions: Detection Mechanisms and Testing Strategies. Translational Vision Science and Technology, 5(3), 1-13. [More Information]

2015

  • Simunovic, M., Maberley, D. (2015). Anti-Vascular Endothelial Growth Factor Therapy For Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis. Retina, 35(10), 1931-1942. [More Information]
  • Simunovic, M. (2015). Metamorphosia and its quantification. Retina, 35(7), 1285-1291. [More Information]
  • Simunovic, M., Thaung, C., da Cruz, L., Sagoo, M., Egan, C. (2015). Small cell carcinoma of the lung metastatic to the retina: A clinicopathologic case report. Canadian Journal of Ophthalmology, 50(6), e119-e121. [More Information]

2014

  • Simunovic, M. (2014). "The el greco fallacy" fallacy. JAMA Ophthalmology, 132(4), 491-494. [More Information]
  • Rush, R., Simunovic, M., Sheth, S., Chang, A., Hunyor, A. (2014). 23-Gauge Pars Plana Vitrectomy Versus Scleral Buckling Versus Combined Pars Plana Vitrectomy-Scleral Buckling for Medium-Complexity Retinal Detachment Repair. Asia-Pacific Journal of Ophthalmology, 3(4), 215-219. [More Information]
  • Simunovic, M., Maberley, D. (2014). Familial exudative vitreoretinopathy mimicking macular telangiectasia type 1. Canadian Journal of Ophthalmology, 49(1), e28-e30. [More Information]

2013

  • Rush, R., Simunovic, M., Sheth, S., Kratz, A., Hunyor, A. (2013). Pars Plana Vitrectomy Versus Combined Pars Plana Vitrectomy-Scleral Buckle for Secondary Repair of Retinal Detachment. Ophthalmic Surgery Lasers & Imaging, 44(4), 374-379. [More Information]
  • Rush, R., Simunovic, M., Hunyor, A. (2013). Twenty-Three-Gauge Pars Plana Vitrectomy With Inferior Retinectomy and Postoperative Perfluoro-n-Octane Retention for Retinal Detachment Repair. Asia-Pacific Journal of Ophthalmology, 2, 232-236. [More Information]

2012

  • Simunovic, M. (2012). Dawbeney Turbervile, MD (1612-1696). Archives of Ophthalmology, 130(3), 406-408. [More Information]
  • Simunovic, M., Rush, R., Hunyor, A., Chang, A. (2012). Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. British Journal of Ophthalmology, 96(6), 862-866. [More Information]
  • Simunovic, M. (2012). On seeing yellow: the case for, and against, short-wavelength light-absorbing intraocular lenses. Archives of Ophthalmology, 130(7), 919-926. [More Information]

2011

  • Simunovic, M. (2011). Blue-blocking IOLs. Ophthalmology, 118(9), 1897-1898. [More Information]

2010

  • Simunovic, M. (2010). Colour vision deficiency. Eye, 24(5), 747-755. [More Information]
  • Hughes, E., Guzowski, M., Simunovic, M., Hunyor, A., McCluskey, P. (2010). Syphilitic retinitis and uveitis in HIV-positive adults. Clinical and Experimental Ophthalmology, 38(9), 851-856. [More Information]

2009

  • Simunovic, M., Hughes, E., Townend, B., Ho, I. (2009). Acute annular outer retinopathy with systemic symptoms [To the Editor]. Eye, 24(6), 1125-1126. [More Information]

2005

  • Michaelides, M., Johnson, S., Simunovic, M., Bradshaw, K., Holder, G., Mollon, J., Moore, A., Hunt, D. (2005). Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals. Eye, 19(1), 2-10. [More Information]
  • Michaelides, M., Johnson, S., Bradshaw, K., Holder, G., Simunovic, M., Mollon, J., Moore, A., Hunt, D. (2005). X-Linked Cone Dysfunction Syndrome with Myopia and Protanopia. Ophthalmology, 112(8), 1448.e1-1448.e9. [More Information]

2004

  • Simunovic, M., Calver, R. (2004). Crowding under scotopic conditions. Vision Research, 44(10), 963-969. [More Information]
  • Simunovic, M., Cullerne, A., Colley, A., Wilson, T. (2004). How Well Does Color Perimetry Isolate Responses from Individual Cone Mechanisms? Journal of Glaucoma, 13(1), 22-27. [More Information]

Selected Grants

2023

  • Optogenetic Approaches For Vision Restoration, Too L, Simunovic M, Protti D, Lisowski L, Australian Vision Research (AVR)/Australian Vision Research Grants
  • Rewarding Research 2024, Simunovic M, Faculty of Medicine and Health/FMH Rewarding Research Success
  • High-density microelectrode array (HD-MEA), Simunovic M, National Health and Medical Research Council (NHMRC)/Equipment Grant
  • Collagen Bioglue for Retinal Detachment Repair, Simunovic M, You J, Fan J, The Macula Society/International Retinal Research Foundation Award

2022

  • Cell Therapy Via Living Donor surgical retinal explants, Simunovic M, Protti D, Too L, Sydney Eye Hospital Foundation/Research Grant
  • DEVELOPMENT OF PHOTORECEPTOR CELL THERAPY TO TREAT BLINDNESS, Elwood N, Gonzalez Cordero A, Wakefield C, Yang P, Hetherington K, Jamieson R, Reddel R, Simunovic M, Tam P, Grigg J, Zreiqat H, Department of Health and Aged Care (Federal - administered by NHMRC)/2021 MRFF Stem Cell Therapies Mission